Validation and utility of plasma neurofilament light as a biomarker for vascular cognitive impairment

Autor: Tiffany F Kautz, Julia J Mathews, Danielle Parent, Tiffany L Sudduth, Qianqian Liu, Crystal Wiedner, Chen‐Pin Wang, Djass Mbangdadji, Joshua C Bis, Abhay P Sagare, Alexa S Beiser, George Pottanat, Hugo J Aparicio, Jeffery F Thompson, Kelsey Erickson, Lee‐Way Jin, Mitzi M Gonzales, Saptaparni Ghosh, Charles S. DeCarli, Danny JJ Wang, Donna M Wilcock, Gary A Rosenberg, Hanzhang Lu, Joel H. Kramer, Lenore J. Launer, Myriam Fornage, Thomas H Mosley, Pauline Maillard, Vilmundur Gudnason, Herpreet Singh, Karl G Helmer, Kristin Schwab, Steven M Greenberg, Russell P. Tracy, Pia Kivisäkk, Sudha Seshadri, Claudia L Satizabal

Publikováno v: Alzheimer's & Dementia. 18

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c02b7785cd5d3881d9ee8126d82583e6
https://doi.org/10.1002/alz.065811

Cerebral small vessel disease burden is associated with decreased abundance of gut Barnesiella intestinihominis bacterium in the Framingham Heart Study.

Autor: Fongang B; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. fongang@uthscsa.edu.; Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. fongang@uthscsa.edu.; Department of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. fongang@uthscsa.edu., Satizabal C; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Department of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Framingham Heart Study, Framingham, MA, USA.; Department of Neurology, Boston University School of Medicine, Boston, MA, USA., Kautz TF; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Wadop YN; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Muhammad JAS; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Vasquez E; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Mathews J; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Gireud-Goss M; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Saklad AR; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Himali J; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Department of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Framingham Heart Study, Framingham, MA, USA.; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.; Department of Neurology, Boston University School of Medicine, Boston, MA, USA., Beiser A; Framingham Heart Study, Framingham, MA, USA.; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.; Department of Neurology, Boston University School of Medicine, Boston, MA, USA., Cavazos JE; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Mahaney MC; Department of Human Genetics, South Texas Diabetes and Obesity Institute, The University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA., Maestre G; Department of Neurosciences and Department of Human Genetics, University of Texas Rio Grande Valley School of Medicine, Brownsville, TX, USA., DeCarli C; Department of Neurology, Alzheimer's Disease Center, University of California, Davis, Sacramento, CA, USA., Shipp EL; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Vasan RS; Framingham Heart Study, Framingham, MA, USA.; Department of Medicine, Section of Cardiovascular Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA.; Department of Medicine, Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, MA, USA.; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.; Boston University's Center for Computing and Data Sciences, Boston, MA, USA.; The University of Texas School of Public Health in San Antonio, San Antonio, TX, USA.; The Long School of Medicine, University of Texas Health Science Center, San Antonio, TX, USA., Seshadri S; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.; Framingham Heart Study, Framingham, MA, USA.; Department of Neurology, Boston University School of Medicine, Boston, MA, USA.; Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Publikováno v: Scientific reports [Sci Rep] 2023 Aug 21; Vol. 13 (1), pp. 13622. Date of Electronic Publication: 2023 Aug 21.